GLP-1 medications like Ozempic, Wegovy, and Mounjaro have transformed the weight loss journey for many people
Seguiamo le direttive della Regione Lazio per la lotta integrata regionale dal 1992, applicando un uso razionale e limitato di concimi chimici e fitofarmaci
Built for patients using GLP-1 medications, Pivot bridges the gap between prescription and daily adherence, delivering dose tracking, habit logging, and personalized insights that keep users consistent, informed, and motivated
Ozempic and Wegovy alone accounted for $26 billion in annual sales in 2024
Overlooking FDA requirements
While no change in BSEP abundance in NAFLD was reported previously, quantitative estimates of membrane-localized BSEP are lacking, particularly across hepatic regions